La gouvernance

Définir une stratégie ambitieuse

et assurer sa mise en œuvre

La gouvernance de BIOASTER s’appuie sur un Conseil d’Administration et un Comité Stratégique Scientifique.

Philippe Archinard

Philippe Archinard – Président

Le Conseil d’Administration

LYONBIOPÔLE

Teddy Breyton

INSTITUT PASTEUR

Christophe d’Enfert

BIOMÉRIEUX

François Lacoste

BOEHRINGER- INGELHEIM

Christiane Wijsen

CNRS

CEA

Patrick Chaton

DANONE

En cours de nomination

INSERM

Yazdan Yazdanpanah

INSTITUT MÉRIEUX

Philippe Archinard

SANOFI

Paul-Alan Dollinger

UNIVERSITÉ DE LYON

Nathalie Dompnier

SME

Guy-Charles Fanneau de La Horie

SANOFI

Jacques Volckmann

Olivier Dugrip
Recteur de la région académique Auvergne-Rhône-Alpes, Chancelier des universités

LE MONDE VÉTÉRINAIRE

Mireille Bossy

LA METROPOLE DE LYON

Bruno Bernard

RÉGION AUVERGNE RHÔNE-ALPES

Fabrice Pannekoucke

DREETS

Isabelle Notter

Le management

Le management

Alexandre Moulin

Alexandre Moulin
Directeur Général – CEO

Alexandre a rejoint BIOASTER en 2016 en tant que Directeur Général Adjoint, en charge de l’administration et des relations institutionnelles. Précédemment il était  Directeur Général de la Fondation pour l’université de Lyon.
Christophe VEDRINE, PhD.

Christophe VEDRINE, PhD. 

Directeur Scientifique / Directeur des Technologies

CSO/CTO

Christophe Védrine has been a pivotal figure at BIOASTER since 2014, contributing significantly to the institute’s mission of advancing collaborative research and public-private partnerships in Infectious Disease and Microbiology. In 2024 and 2025, he was appointed the position of Chief Technology Officer and then Chief Scientific Officer, playing a crucial role in steering the organization’s scientific endeavors and research directions. He leads and manages a team of around seventy scientists organized into four program teams and five technology units. 

Prior to his current role, Christophe served as a Project Leader at Bio-Rad from 2008 to 2014, where he spearheaded the development of multiplex serological diagnostic kits in virology. His work included the creation of Luminex assays and micro-array assays for simultaneous serological screening of HIV, Hepatitis B, and C infections. He also managed the technology transfer of micro-array technology from an American company to Bio-Rad France. 

Christophe’s career began in 2003 at Biomedical Diagnostics (BMD), where he developed in vitro diagnostic kits using Luminex Technology in collaboration with marketing and instrumentation departments. In 2004, he joined CNAM’s analytical chemistry team as an associate professor, developing new bio-analytical methods and technologies, including whole cell, DNA, and label-free biosensors. He managed a team of engineers, technicians, and PhD students, and established industrial collaborations with Theradiag and several institutional partners. 

Christophe Védrine holds an engineering degree in biotechnology from Université de Technologie de Compiegne (1998), a Master’s degree in cellular and molecular biology from Université Pierre et Marie-Curie (1999), and a PhD in biotechnology from Ecole des Mines de Saint-Etienne (2003).